Amplifon S.p.A. (AMP1N) Price & Analysis
AMP1N Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- MXN 63.51B
- Enterprise Value
- MXN 3.33B
- Total Cash (Recent Filing)
- MXN 0
- Total Debt (Recent Filing)
- MXN 1.08B
- Price to Earnings (P/E)
- 36.8
- Beta
- N/A
- Next Earnings
- Mar 10, 2027
- EPS Estimate
- 3.43
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Operating Profitability
A sustained EBITDA margin around 21–23% shows that Amplifon’s retail clinic and hearing-care service model continues to generate meaningful operating profit. This provides an earnings cushion, supports investment in its distribution network, and indicates that the core business remains economically viable despite weaker net income.
Free Cash Flow Generation
Consistently positive free cash flow, including TTM cash flow above reported net income, supports the quality of Amplifon’s earnings and provides internally generated funding. This can help the company maintain operations, invest in customer services, and manage obligations without relying entirely on external financing.
TTM Revenue Recovery
The sharp TTM revenue rebound suggests that demand and customer activity have improved after a period of broadly stable sales. If sustained, renewed top-line growth would improve operating leverage across Amplifon’s established clinic network and help rebuild earnings momentum over the next several quarters.
Bears Say
Net Margin Compression
Net margin compression to roughly 3% materially reduces the amount of revenue converted into bottom-line earnings. Even with solid EBITDA profitability, persistently weaker net income can constrain reinvestment, reduce resilience against operating pressures, and make future earnings more sensitive to financing and other costs.
Elevated Leverage
Debt consistently exceeding equity leaves Amplifon with less balance-sheet flexibility than a lower-leverage business. Elevated leverage can absorb a greater share of future cash generation through obligations, limit funding capacity for expansion, and increase the consequences of any continued weakness in profitability.
Cash-flow Slowdown
Although free cash flow remains positive, the sharp TTM reduction in operating cash flow and negative recent FCF growth indicate weaker cash conversion momentum. If this persists, Amplifon could have less internally generated capacity to reduce debt, invest in its network, or support shareholder distributions.
AMP1N FAQ
What is Amplifon S.p.A.’s market cap?
When is Amplifon S.p.A.’s upcoming earnings report date?
How were Amplifon S.p.A.’s earnings last quarter?
Is Amplifon S.p.A. overvalued?
Does Amplifon S.p.A. pay dividends?
What is Amplifon S.p.A.’s EPS estimate?
How many shares outstanding does Amplifon S.p.A. have?
What happened to Amplifon S.p.A.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Amplifon S.p.A.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Amplifon S.p.A.
Amplifon S.p.A. delivers extensive hearing care products and services, empowering individuals to reconnect with the world of sound. Their diverse selection of hearing devices includes models such as ampli-easy, ampli-mini, ampli-connect, and ampli-energy, complemented by personalized fitting services for tailored solutions. As of March 18, 2022, the company maintained a substantial global presence, operating approximately 9,200 retail locations across 25 countries and five continents, further extending its reach through 1,350 franchised outlets. Amplifon conducts operations throughout Europe, the Middle East, Africa, the United States, Asia, and Oceania. The company, established in 1950, is headquartered in Milan, Italy.
- Sector
- General
- Industry
- Medical - Distribution
- CEO
- Enrico Vita
- Employees
- 13,435
- Website
- corporate.amplifon.com
- Address
- Via Ripamonti 133, Milan, MI, 20141, IT